Dividends & Buybacks ·
Aethlon Medical, Inc. filed a Certificate of Change with the Nevada Secretary of State on July 30, 2026, authorizing a…
AEMDAethlon Medical Inc
Aethlon Medical, Inc. filed a Certificate of Change with the Nevada Secretary of State on July 30, 2026, authorizing a one-for-five reverse stock split of its common stock. The transaction becomes effective at 10:00 a.m. Eastern Time on July 31, 2026, with split-adjusted trading expected to commence on August 4, 2026. The company stated the move supports capital markets strategy and compliance with Nasdaq Listing Rule 5550(a)(2). Authorized shares will decrease from 100 million to 20 million, reducing outstanding shares from approximately 3.25 million to roughly 649,914. Fractional shares are rounded up to whole shares rather than paid out in cash. Aethlon Medical, Inc. operates in the medical device industry, specializing in extracorporeal blood purification technologies.